HOME >> MEDICINE >> NEWS
New alzheimer's drug shows promise in clinical trial

Washington, DC--The only drugs currently available for Alzheimer's patients are those that alleviate symptoms, but a team of scientists led by Paul Aisen, MD, director of the Memory Disorders program at Georgetown University Medical Center, is testing a new class of drugs that actually target the molecule believed to cause the disease. Aisen and his colleagues report that a compound called tramiprosate reduced levels of a marker for the progression of Alzheimer's disease in a Phase II clinical trial in the November 1 electronic version of Neurology.

"Everyone wants to figure out how to create an Alzheimer's treatment that attacks the amyloid peptide, which is considered to be the molecular cause of the disease," said Aisen. "This is the most advanced anti-amyloid treatment that exists--it has the potential for slowing down progression of the disease."

Aisen and his team are currently in the midst of Phase III clinical trials on tramiprosate (manufactured by Neurochem, for which Aisen is a scientific advisor, as ALZHEMEDTM) and hope to have results by early next summer. Media should call 202-687-5100 to schedule an interview with Aisen or to be connected with another Georgetown expert on the topic.


'"/>

Contact: Becky Wexler
rjw43@georgetown.edu
202-687-5100
Georgetown University Medical Center
2-Nov-2006


Page: 1

Related medicine news :

1. New study shows promise in reducing surgical risks associated with surgical bleeding
2. Most seniors now have drug coverage, U-M study shows
3. Wireless technology shows promise in diagnosing pediatric intestinal disease
4. Study shows radiofrequency ablation highly effective in treating kidney tumors
5. Method shows promise for early detection of pancreatic cancer
6. Organic farming can feed the world, U-M study shows
7. New study shows Rescue Remedy is an effective all-natural stress, anxiety reliever
8. Borderline personality disorder shows improvements with intensive psychotherapy
9. New drug shows promise in treatment of advanced thyroid cancer
10. Study shows Diachrome improves blood sugar control in people with type 2 diabetes
11. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... , ... August 05, 2020 , ... ... the appointments of Kathleen Cruger as Director of Clinical Services and Myron Falchuk, ... company’s growth. , “ChronWell has achieved incredible growth as demand for ...
(Date:8/5/2020)... ... August 04, 2020 , ... Total Spectrum, a company of ... in Wisconsin, is delighted to announce the grand opening of their new ... center, Total Spectrum now proudly serves ten different locations across the Midwest. The ...
(Date:8/3/2020)... ... August 03, 2020 , ... WorkBook6 – a Tempe, Arizona-based ... The site provides a simple and efficient way for Americans over the age ... as an important expansion for the insurance marketing ecosystem, and a critical service ...
(Date:7/31/2020)... ... July 31, 2020 , ... ... new patients to The Dental Studio of Midland for groundbreaking laser dentistry ... a result, these patients are able to experience the many advantages of laser ...
(Date:7/22/2020)... CHICAGO (PRWEB) , ... July 22, 2020 , ... As part of August’s Children’s Eye ... Center for Children’s Vision and Eye Health at Prevent Blindness (NCCVEH) has released an ... Current National Issues 2nd Edition . The goal of the report is , ...
Breaking Medicine News(10 mins):
(Date:8/3/2020)... YORK (PRWEB) , ... August 03, 2020 , ... ... health and science innovations, today announced that Donna L. LaVoie, President, CEO and Founder ... in the life-sciences industry. , Since 2005, the PharmaVOICE 100 has honored more ...
(Date:7/31/2020)... , ... July 31, 2020 , ... Member Care Solutions ... nation’s largest urgent care clinic operators the licensing of their cloud based membership management ... Member Care Solutions client family. Our software is the perfect match for many reasons, ...
(Date:7/22/2020)... ... July 22, 2020 , ... TrialScope, the ... announce the addition of Moderna to its growing customer roster. , TrialScope customers ... for trial disclosure management, patient engagement and study recruitment. Collectively, TrialScope customers are ...
Breaking Medicine Technology:
Cached News: